Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

WelChol® With Metformin in Treating Patients With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00147719

Public ClinicalTrials.gov record NCT00147719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Monotherapy or Metformin Therapy in Combination With Other Oral Anti-Diabetic Agents

Study identification

NCT ID
NCT00147719
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Colesevelam hydrochloride Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2004
Primary completion
Jun 30, 2006
Completion
Jun 30, 2006
Last update posted
Jan 17, 2012

2004 – 2006

United States locations

U.S. sites
46
U.S. states
22
U.S. cities
46
Facility City State ZIP Site status
CRO Jonesboro Arkansas
Not listed Beverly Hills California
Not listed Carmichael California
Not listed Fresno California
Not listed Irvine California
Not listed La Jolla California
Not listed Los Gatos California
Not listed San Diego California
Not listed Spring Valley California
Not listed West Hills California
Not listed Washington D.C. District of Columbia
Not listed Coco Beach Florida
Not listed Largo Florida
Not listed Miami Florida
Not listed Pembroke Pines Florida
Not listed West Palm Beach Florida
Not listed Atlanta Georgia
Not listed Evansville Indiana
Not listed Louisville Kentucky
Not listed Detroit Michigan
Not listed Troy Michigan
Not listed Edina Minnesota
Not listed Chesterfield Missouri
Not listed Bozeman Montana
Not listed Butte Montana
Not listed Las Vegas Nevada
Not listed Rochester New York
Not listed Charlotte North Carolina
Not listed Winston-Salem North Carolina
Not listed Cincinnati Ohio
Not listed Cleveland Ohio
Not listed Lyndhurst Ohio
Not listed Marion Ohio
Not listed Oklahoma City Oklahoma
Not listed Tulsa Oklahoma
Not listed Portland Oregon
Not listed Beaver Pennsylvania
Not listed Charleston South Carolina
Not listed Columbia South Carolina
Not listed Morristown Tennessee
Not listed Corpus Christi Texas
Not listed Dallas Texas
Not listed Pharr Texas
Not listed San Antonio Texas
Not listed Arlington Virginia
Not listed Richmond Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00147719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2012 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00147719 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →